Načítá se...
A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
Signal Transducer and Activator of Transcription 3 (STAT3) is persistently activated in human liver and colon cancer cells and is required for cancer cell viability, survival and migration. Therefore, inhibition of STAT3 signaling may be a viable therapeutic approach for these two cancers. We recent...
Uloženo v:
Vydáno v: | Oncotarget |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Impact Journals LLC
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4914331/ https://ncbi.nlm.nih.gov/pubmed/26883202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7338 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|